Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Revance Therapeutics Inc. logo

Revance Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

2.66
 
USD
  
-0.21
  
(-7.32%)
Optionable: Yes  Market Cap: 292 M  90-day average vol: 1,867,371

Previous close: 2.87  Open: 2.89  Bid: 2.7  Ask: 2.9
52 week range    
2.57   
   26.76
Last updated: Monday 24th June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

RVNC Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AccruedPreferredStockDividends63 M73 M282 M281 M
Amortization of intangibles147 M147 M77 M
Basic EPS from continuing operations-3.67-4.86-4.17-4.9-3.83
Basic EPS total-3.24-3.02-3.67-4.86-4.17-4.9-3.83
Basic weighted shares outstanding19 M24 M28 M30 M36 M43 M58 M68 M73 M85 M
CommissionExpenses14 M
Cost of sales5 M23 M52 M74 M
Depreciation-2 M-2 M-1 M-1 M14 M28 M6 M
Depreciation unreconciled14 M28 M6 M
DepreciationAndAmortization-2 M-2 M-1 M-1 M14 M28 M6 M
DevelopmentExpense6 M
Diluted EPS total-3.24-3.02-3.18-4.01-3.94-3.67-4.86-4.17-4.9-3.83
Diluted normalized net income/share-4.17-4.9-3.83
Diluted weighted shares outstanding19 M24 M28 M30 M36 M43 M58 M68 M73 M85 M
Earnings from equity interest-140000.0
EarningsFromEquityInterestNetOfTax-140000.0
GainOnSaleOfPPE1 M
GainOnSaleOfSecurity4 M231000.01 M1 M4 M6 M4 M337000.05 M13 M
GeneralAndAdministrativeExpense-5 M-5 M-5 M-5 M-5 M62 M158 M199 M224 M298 M
Gross operating profit383000.0300000.0300000.0262000.04 M413000.011 M54 M81 M160 M
ImpairmentOfCapitalAssets9 M3 M70 M93 M
Income before tax-61 M-74 M-89 M-121 M-140 M-159 M-285 M-281 M-356 M-324 M
Income taxes-537000.0-607000.0-11000.0-63 M3 M-3 M700000.0300000.0
InterestExpenseNonOperating11 M1 M1 M457000.044000.015 M6 M16 M19 M
InterestExpenseOperating-1 M-802000.0-676000.04 M5 M12 M15 M
MiscOtherSpecialCharges-2 M-327000.0-535000.0-525000.0-773000.0-303000.0-592000.0-698000.0-2 M-838000.0
Net income from total operations-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M-356 M-324 M
NetIncomeCommonStockholders-126 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M-356 M-324 M
NetIncomeContinuousOperations-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M-356 M-324 M
NetIncomeFromOtherGainsLosses-2 M127000.0-608000.0-591000.0
NetNonOperatingInterestIncomeExpense-11 M-1 M-1 M-457000.0-44000.0-15 M-6 M-16 M-19 M
Operating income-52 M-72 M-79 M-117 M-143 M-164 M-273 M-275 M-342 M-317 M
Operating income before depreciation (EBITDA)-48 M-71 M-86 M-118 M-139 M-159 M-245 M-249 M-289 M-280 M
OperatingExpense-52 M-73 M-89 M-121 M-146 M165 M288 M352 M475 M551 M
Other income net-2 M96000.0-635000.0-294000.0-3 M-5 M-4 M361000.0-3 M-12 M
OtherGandA-5 M-5 M-5 M-5 M-5 M62 M158 M199 M224 M298 M
OtherOperatingExpenses-196000.0-259000.0-273000.0-758000.0-1 M-1 M-1 M-588000.0-1 M-2 M
OtherunderPreferredStockDividend63 M73 M282 M281 M
PreferredStockDividends63 M73 M282 M281 M
PromotionAndAdvertising6 M5 M8 M
RealizedCapitalGain-591000.0-140000.0
RentAndLandingFees-5 M-5 M-5 M-5 M-5 M6 M
Research & development expense33 M48 M50 M80 M93 M103 M126 M116 M101 M79 M
ResearchExpense33 M48 M50 M80 M93 M103 M126 M116 M101 M79 M
Revenue per share-1 M-5000.0157 M147 M107 M9 M
SalariesAndWages-7 M-12 M-12 M-13 M-16 M55 M52 M
Selling Gen & administrative expense19 M25 M29 M37 M54 M62 M158 M199 M224 M298 M
SellingAndMarketingExpense19 M25 M29 M37 M54 M6 M5 M8 M
SellingExpense19 M25 M29 M37 M54 M
Special income/charges-9 M-3 M-70 M-93 M
Total Income available for interest expense (EBIT)-52 M-73 M-88 M-120 M-140 M-159 M-265 M-270 M-327 M-289 M
Total common shares outstanding24 M28 M29 M37 M44 M57 M71 M71 M83 M88 M
Total net income-63 M-73 M-89 M-121 M-143 M-159 M-282 M-281 M-356 M-324 M
Total ordinary shares104 M104 M104 M104 M104 M104 M104 M104 M104 M104 M
Total revenues383000.0300000.0300000.0262000.04 M413000.015 M78 M133 M234 M
TotalExpenses-52 M-73 M-89 M-121 M-146 M165 M293 M376 M526 M625 M
TotalRevenue383000.0300000.0300000.0262000.04 M413000.015 M78 M133 M234 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University